GlassScriptPhysician profile
Itay D Melamed
NPI 1619078656
$827.25
in general payments reported to CMS, 2019-2025
9 companies · $573 in 2025
The $573 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.37 · 2020: $16.34 · 2021: $70.16 · 2024: $121 · 2025: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684 · Travel and Lodging: $10.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.91 |
| Travel and Lodging | $10.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $208.52 | 2021-2025 | Pipeline, Synchromedii |
| Alafair Biosciences, INC. | $169.44 | 2025 | Versawrap |
| Depuy Synthes Sales INC. | $142.95 | 2025 | Trufill |
| Globus Medical, INC. | $142.89 | 2025 | Coalition Agx, Bendini, Simplify Cervical Artificial Disc |
| Route 92 Medical, INC. | $73.53 | 2024 | 8f Base Camp Sheath System |
| Stryker Corporation | $31.03 | 2019 | |
| Imperative Care, INC | $27.21 | 2024 | Zoom 88-T Large Distal Platform |
| Csl Behring | $16.34 | 2020 | |
| Endo Pharmaceuticals INC. | $15.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Itay Melamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.